Bioengineered chitosan/silk scaffold encapsulated with quercetin nanoparticles accelerates wound healing in a diabetic rat skin defect model
- PMID: 40929763
- DOI: 10.1016/j.tice.2025.103119
Bioengineered chitosan/silk scaffold encapsulated with quercetin nanoparticles accelerates wound healing in a diabetic rat skin defect model
Abstract
Chronic wounds, particularly in diabetic patients, are characterized by prolonged inflammation, impaired angiogenesis, and delayed tissue regeneration. To address these challenges, the author developed a bioactive scaffold by incorporating quercetin nanoparticles (Qn) into a chitosan/silk fibroin (ChS) matrix, aiming to accelerate and enhance the wound healing process. Quercetin nanoparticles were synthesized via a solvent displacement method and incorporated into a ChS scaffold using a blending and freeze-drying technique. The physicochemical properties of the scaffold, including porosity, swelling ratio, degradation profile, biocompatibility, mechanical properties, and drug release kinetics, were characterized. Full-thickness excisional wounds (20 mm) were created on the dorsum of streptozotocin-induced diabetic Wistar rats, which were divided into three groups (n = 5): untreated control, ChS, and Qn-loaded ChS (QnChS). Wound closure was monitored on days 7 and 14. Histological evaluations (H&E and Masson's Trichrome) assessed tissue regeneration, vascularization, and collagen deposition. Cytokine levels (bFGF, VEGF, TNF-α, IL-1β) were quantified using ELISA. The QnChS scaffolds displayed a porous structure with sustained drug release over 14 days and enhanced biodegradability. In vivo, the QnChS group showed significantly accelerated wound contraction, increased dermal thickness and epidermal length, and higher collagen deposition compared to the other groups (p < 0.05). Angiogenesis was notably improved, evidenced by a higher number of blood vessels and elevated VEGF levels. Additionally, QnChS scaffolds markedly reduced TNF-α and IL-1β while increasing bFGF expression, indicating enhanced resolution of inflammation and promotion of tissue regeneration. The Qn-loaded ChS scaffold effectively modulates the inflammatory response, promotes angiogenesis, and enhances dermal regeneration in diabetic wounds. These findings suggest its potential as a multifunctional wound dressing for managing chronic wounds in diabetic patients.
Keywords: Chitosan; Diabetes; Nanoparticles; Quercetin; Rat skin; Scaffold; Silk; Wound healing.
Copyright © 2025 Elsevier Ltd. All rights reserved.
Similar articles
-
Bioinspired Collagen Scaffold Loaded with bFGF-Overexpressing Human Mesenchymal Stromal Cells Accelerating Diabetic Skin Wound Healing via HIF-1 Signal Pathway Regulated Neovascularization.ACS Appl Mater Interfaces. 2024 Sep 4;16(35):45989-46004. doi: 10.1021/acsami.4c08174. Epub 2024 Aug 21. ACS Appl Mater Interfaces. 2024. PMID: 39165237 Free PMC article.
-
The effect of chitosan/alginate hydrogel loaded quercetin on wound healing in diabetic rat model.J Mol Histol. 2025 Jul 12;56(4):225. doi: 10.1007/s10735-025-10508-1. J Mol Histol. 2025. PMID: 40650827
-
Poly glycerol sebacate/poly lactide acid (PGS/PLA) hydrogel in combination with hyperbaric oxygen therapy improved full thickness wound healing in diabetic rat.Tissue Cell. 2025 Aug 29;98:103113. doi: 10.1016/j.tice.2025.103113. Online ahead of print. Tissue Cell. 2025. PMID: 40896868
-
Biocompatible nanostructured chitosan scaffolds for enhanced diabetic wound healing: Innovations and strategies.3 Biotech. 2025 Jul;15(7):221. doi: 10.1007/s13205-025-04377-4. Epub 2025 Jun 21. 3 Biotech. 2025. PMID: 40551969 Review.
-
Topical antimicrobial agents for treating foot ulcers in people with diabetes.Cochrane Database Syst Rev. 2017 Jun 14;6(6):CD011038. doi: 10.1002/14651858.CD011038.pub2. Cochrane Database Syst Rev. 2017. PMID: 28613416 Free PMC article.
LinkOut - more resources
Full Text Sources